Insulet Corp (MEX:PODD)
MXN 4702.68 0 (0%) Market Cap: 372.46 Bil Enterprise Value: 382.28 Bil PE Ratio: 45.89 PB Ratio: 16.81 GF Score: 87/100

Insulet Corp at Cowen Health Care Conference Transcript

Mar 12, 2019 / 04:00PM GMT
Doug Schenkel
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

All right. It's the last session before lunch, and it's a good one. It's my pleasure to welcome Insulet back to the conference. With us from the company, we have Shacey Petrovic, the President and Chief Executive Officer. We have other folks from the company here as well. I know we're in good hands with you, Shacey, but just in case, we've got a solid bench with us today as well. So lots to cover, I thought we would dig in a bit talking about recent trends in the U.S. on Omnipod and some of the product enhancements that are in the works. Of course, I think, international is going to be of interest to folks given some of the robust progress that's been made there. And beyond that, it would be good to talk a bit more -- in a bit more detail about the product pipeline. So I thought we'd kick off this time about U.S. Omnipod. You want to just get into it?

Shacey Petrovic
Insulet Corporation - President, CEO & Director

Sure. Yes, great.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot